Confirm the syndrome before treating it as Alzheimer’s or Parkinson’s disease
Charité’s memory clinic evaluates Lewy-body dementia alongside Alzheimer’s disease, frontotemporal dementia and other cognitive disorders. Heidelberg includes DLB in its specialist clinic for atypical parkinsonian syndromes. The diagnosis depends heavily on the pattern and timing of cognitive, behavioral, sleep and motor symptoms rather than on memory loss alone.
- Cognitive decline and effect on daily function
- Marked fluctuations in attention or alertness
- Recurrent well-formed visual hallucinations
- REM-sleep behavior symptoms such as acting out dreams
- Bradykinesia, rigidity, tremor or postural instability
- Falls, fainting, urinary or other autonomic symptoms when present
DLB and Parkinson’s disease dementia are related but not identical
Heidelberg explains that dementia is the leading syndrome in DLB and appears before or at about the same time as motor parkinsonism, whereas dementia in Parkinson’s disease typically develops later in an already established Parkinson’s course. This distinction matters because prognosis, medication tolerability and the diagnostic pathway can differ.
Neuropsychology and MRI are core parts of diagnostic clarification
A German second opinion may include detailed history from the patient and a close relative, neurological examination, structured cognitive testing and review of brain MRI. Charité also documents CSF biomarker testing in its dementia work-up. Heidelberg lists MRI, CSF and selected functional imaging among tools that can help distinguish atypical parkinsonian disorders when the diagnosis remains uncertain.
- Neuropsychological profile rather than a single screening score
- Brain MRI to look for alternative or contributory pathology
- Medication review for drugs that can worsen cognition or alertness
- Selected CSF testing when another dementia process is suspected
- Selected dopaminergic or metabolic imaging when the specialist believes it will change the differential diagnosis
Medication must be introduced cautiously
Freiburg and Heidelberg both emphasize that people with Lewy-body disease may react sensitively to medicines used for parkinsonian symptoms or hallucinations. Treatment should therefore be individualized, started cautiously and monitored for worsening confusion, sedation, rigidity, blood-pressure problems or other adverse effects. Medication changes should not be made from an online list without specialist supervision.
Cholinesterase-inhibitor treatment may help selected cognitive or behavioral symptoms
Freiburg’s LBD patient information notes that cholinesterase inhibitors can reduce symptoms for some patients. They are symptom-directed treatment rather than a cure and should be considered in the context of cardiovascular status, other medicines, cognitive symptoms and tolerability.
Hallucinations require careful risk-benefit assessment
Visual hallucinations are a core LBD feature and do not automatically require antipsychotic treatment. Freiburg notes that only a limited number of antipsychotic medicines are well tolerated in Lewy-body disease. A specialist should first determine whether hallucinations are distressing or dangerous, review triggers such as infection or medication changes and weigh treatment against the risk of severe sensitivity reactions.
Non-drug care is a major part of the pathway
Freiburg highlights cognitive activation, physiotherapy, occupational therapy, environmental adaptation and support for daily activities. Depending on symptoms, a German multidisciplinary plan can also address mobility, fall prevention, swallowing, sleep, caregiver education and practical home-safety needs. These measures remain important because no available medicine reverses the underlying disease.
Rapid deterioration should not be assumed to be normal DLB progression
DLB usually progresses over time, but abrupt or rapidly worsening confusion, reduced consciousness, new focal neurological deficits, fever, severe dehydration or a major change after a medication adjustment requires prompt local assessment. Infection, stroke, metabolic disturbance, medication toxicity and other acute problems can cause delirium on top of chronic dementia and should not wait for international travel.
What to send for a German LBD second opinion
The most useful record package shows the chronology of cognitive, behavioral, sleep and motor symptoms and any previous medication sensitivity.
- Neurology, psychiatry, geriatrics or memory-clinic reports
- Neuropsychological and cognitive testing results
- Brain MRI/CT reports and original images
- CSF or functional-imaging results if already performed
- A timeline of cognitive symptoms relative to parkinsonian symptoms
- Description of hallucinations, cognitive fluctuations and REM-sleep behavior
- Current medication list and previous adverse drug reactions
- Falls, orthostatic symptoms, swallowing and sleep history
- A specific question: confirm DLB, distinguish it from Parkinson’s disease dementia/Alzheimer’s disease or optimise symptom treatment
Official sources
Sources last checked 2026-09-01. Clinical pathways, eligibility and hospital procedures can change; confirm current requirements directly with the treating center.
- Atypical Parkinson syndromes / dementia with Lewy bodies — Heidelberg University Hospital ↗
- Outpatient clinic for atypical Parkinson syndromes — Heidelberg University Hospital ↗
- Dementia and cognitive disorders / memory clinic — Charité – Universitätsmedizin Berlin ↗
- Lewy-body disease overview — University Medical Center Freiburg ↗